Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesAsset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Exchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesGains from Sales and DivestituresGains from Sales and DivestituresNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Insight Molecular Diagnostics (IMDX) Free Cash Flow (2016 - 2026)

Insight Molecular Diagnostics' Free Cash Flow history spans 6 years, with the latest figure at -$7.0 million for Q4 2025.

  • On a quarterly basis, Free Cash Flow fell 26.22% to -$7.0 million in Q4 2025 year-over-year; TTM through Dec 2025 was -$25.4 million, a 19.64% decrease, with the full-year FY2025 number at -$25.4 million, down 19.64% from a year prior.
  • Free Cash Flow hit -$7.0 million in Q4 2025 for Insight Molecular Diagnostics, down from -$5.6 million in the prior quarter.
  • Over the last five years, Free Cash Flow for IMDX hit a ceiling of -$3.2 million in Q3 2023 and a floor of -$14.8 million in Q1 2022.
  • Historically, Free Cash Flow has averaged -$7.9 million across 5 years, with a median of -$6.9 million in 2023.
  • Biggest five-year swings in Free Cash Flow: soared 73.85% in 2023 and later crashed 75.26% in 2024.
  • Tracing IMDX's Free Cash Flow over 5 years: stood at -$7.5 million in 2021, then crashed by 39.97% to -$10.4 million in 2022, then soared by 55.14% to -$4.7 million in 2023, then decreased by 18.71% to -$5.6 million in 2024, then dropped by 26.22% to -$7.0 million in 2025.
  • Business Quant data shows Free Cash Flow for IMDX at -$7.0 million in Q4 2025, -$5.6 million in Q3 2025, and -$6.6 million in Q2 2025.